Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Jun;134(6):812-816.e2.
doi: 10.1016/j.amjmed.2021.01.020. Epub 2021 Feb 20.

SARS-CoV-2 Infection Hospitalization Rate and Infection Fatality Rate Among the Non-Congregate Population in Connecticut

Shiwani Mahajan  1 , César Caraballo  1 , Shu-Xia Li  2 , Yike Dong  2 , Lian Chen  2 , Sara K Huston  3 , Rajesh Srinivasan  3 , Carrie A Redlich  4 , Albert I Ko  5 , Jeremy S Faust  6 , Howard P Forman  7 , Harlan M Krumholz  8
Affiliations

SARS-CoV-2 Infection Hospitalization Rate and Infection Fatality Rate Among the Non-Congregate Population in Connecticut

Shiwani Mahajan et al. Am J Med. 2021 Jun.

Abstract

Background: Infection fatality rate and infection hospitalization rate, defined as the proportion of deaths and hospitalizations, respectively, of the total infected individuals, can estimate the actual toll of coronavirus disease 2019 (COVID-19) on a community, as the denominator is ideally based on a representative sample of a population, which captures the full spectrum of illness, including asymptomatic and untested individuals.

Objective: To determine the COVID-19 infection hospitalization rate and infection fatality rate among the non-congregate population in Connecticut between March 1 and June 1, 2020.

Methods: The infection hospitalization rate and infection fatality rate were calculated for adults residing in non-congregate settings in Connecticut prior to June 2020. Individuals with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) antibodies were estimated using the seroprevalence estimates from the recently conducted Post-Infection Prevalence study. Information on total hospitalizations and deaths was obtained from the Connecticut Hospital Association and the Connecticut Department of Public Health, respectively.

Results: Prior to June 1, 2020, nearly 113,515 (90% confidence interval [CI] 56,758-170,273) individuals were estimated to have SARS-CoV-2 antibodies, and there were 7792 hospitalizations and 1079 deaths among the non-congregate population. The overall COVID-19 infection hospitalization rate and infection fatality rate were estimated to be 6.86% (90% CI, 4.58%-13.72%) and 0.95% (90% CI, 0.63%-1.90%), respectively, and there was variation in these rate estimates across subgroups; older people, men, non-Hispanic Black people, and those belonging to 2 of the counties had a higher burden of adverse outcomes, although the differences between most subgroups were not statistically significant.

Conclusions: Using representative seroprevalence estimates, the overall COVID-19 infection hospitalization rate and infection fatality rate were estimated to be 6.86% and 0.95%, respectively, among community residents in Connecticut.

Keywords: COVID-19; Infection fatality rate; Infection hospitalization rate; SARS-CoV-2; Seroprevalence.

PubMed Disclaimer

References

    1. Niforatos JD, Melnick ER, Faust JS. Covid-19 fatality is likely overestimated. BMJ. 2020;368:m1113. - PubMed
    1. Centers for Disease Control and Prevention. HHS announces CARES Act funding distribution to States and Localities in support of COVID-19 response. Available at: https://www.cdc.gov/media/releases/2020/p0423-CARES-act.html. Accessed December 14, 2020.
    1. Mahajan S, Srinivasan R, Redlich CA, et al. Seroprevalence of SARS-CoV-2-specific IgG antibodies among adults living in Connecticut: Post-Infection Prevalence (PIP) Study. Am J Med. 2020 Oct 29 doi: 10.1016/j.amjmed.2020.09.024. [online ahead of print] S0002-9343(20)30909-8. - DOI - PMC - PubMed
    1. Blackburn J, Yiannoutsos CT, Carroll AE, Halverson PK, Menachemi N. Infection fatality ratios for COVID-19 among noninstitutionalized persons 12 and older: results of a random-sample prevalence study. Ann Intern Med. 2021;174(1):135–136. - PMC - PubMed
    1. Erikstrup C, Hother CE, Pedersen OBV, et al. Estimation of SARS-CoV-2 infection fatality rate by real-time antibody screening of blood donors. Clin Infect Dis. 2021;72(2):249–253. - PMC - PubMed

Publication types

MeSH terms